Literature DB >> 28089155

Prognostic value of body mass index in transcatheter aortic valve implantation: A "J"-shaped curve.

Rocío González-Ferreiro1, Antonio J Muñoz-García2, Diego López-Otero3, Pablo Avanzas4, Isaac Pascual4, Juan H Alonso-Briales2, Ramiro Trillo-Nouche5, Federico Pun4, Manuel F Jiménez-Navarro2, José M Hernández-García2, César Morís4, José R González Juanatey5.   

Abstract

OBJECTIVES: We aimed to determine whether body mass index (BMI) is a prognostic indicator for long-term, all-cause mortality in patients undergoing transcatheter aortic valve implantation (TAVI).
BACKGROUND: Obesity in patients with established cardiovascular disease has previously been identified as an indicator of good prognosis, a phenomenon known as the "obesity paradox". The prognostic significance of BMI in patients with severe aortic stenosis (AoS) undergoing TAVI is a matter of current debate, as published studies are scarce and their results conflicting.
METHODS: This is an observational, retrospective study involving 770 patients who underwent TAVI for AoS. The cohort was divided into three groups based on their BMI: normal weight (≥18.5 to <25kg/m2), overweight (≥25 to <30kg/m2) and obese (≥30kg/m2). The predictive effect of BMI on all-cause mortality 3years following TAVI intervention was analysed using a Cox regression.
RESULTS: 155 patients died during follow-up. The overweight group (n=302, 38.97%), experienced a lower mortality rate compared to the normal weight and obese groups (15.9% vs 25.7% and 21.0%, respectively [log-rank p-value=0.036]). After adjustment by logistic EuroSCORE, being overweight was found to be an independent protective factor against mortality (HR: 0.63 [95% CI: 0.42 to 0.94], p=0.024). This was not the case for obesity (HR: 0.92 [95% CI: 0.63 to 1.35], p=0.664). We therefore describe for the first time, a "J-shaped" regression curve describing the relationship between BMI and mortality.
CONCLUSIONS: BMI is a predictive factor of all-cause mortality in AoS patients undergoing TAVI. This relationship takes the form of a "J-shaped" curve in which overweight patients are associated with the lowest mortality rate at follow-up. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Body mass index; Mortality; Obesity paradox; Transcatheter aortic valve implantation

Mesh:

Year:  2016        PMID: 28089155     DOI: 10.1016/j.ijcard.2016.12.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Does the "obesity paradox" exist after transcatheter aortic valve implantation?

Authors:  Zeng-Rong Luo; Han-Fan Qiu; Liang-Wan Chen
Journal:  J Cardiothorac Surg       Date:  2022-06-13       Impact factor: 1.522

2.  Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation.

Authors:  M Abawi; R Rozemeijer; P Agostoni; R C van Jaarsveld; C S van Dongen; M Voskuil; A O Kraaijeveld; P A F M Doevendans; P R Stella
Journal:  Neth Heart J       Date:  2017-09       Impact factor: 2.380

3.  Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantation.

Authors:  Astrid C van Nieuwkerk; Raquel B Santos; Samantha Sartori; Ander Regueiro; Didier Tchétché; Roxana Mehran; Ronak Delewi
Journal:  JTCVS Open       Date:  2021-03-23

Review 4.  Preoperative frailty parameters as predictors for outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.

Authors:  M S van Mourik; J F Velu; V R Lanting; J Limpens; B J Bouma; J J Piek; J Baan; J P S Henriques; M M Vis
Journal:  Neth Heart J       Date:  2020-05       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.